Physician

Wade Willis Muncey, M.D.

According to 2025 Medicare claims, Wade Muncey, M.D. (NPI: 1619408838) practices urology in the Boise City, ID market, with the plurality of this provider's patient population coming from Ada, ID. This provider's primary affiliated billing organization is IDAHO UROLOGIC INSTITUTE PA (NPI: 1689620692; TIN: 20-1300128) and primary practice location at 83642-6245. Muncey is affiliated with the Trinity Health Integrated Care (ACO ID: A3454), participating under the MSSP model.

Muncey's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 234 traditional Medicare patients, billed 6,830 HCPCS/CPT codes, and received $234,187 in Medicare payments. The top billing code was G6015 (Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session). Part D data shows 505 prescription claims across 150 beneficiaries totaling $22,592 in drug costs, led by Myrbetriq (Mirabegron). Open Payments data shows 45 records totaling $1,749. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $6,971 to $22,592. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$117K$234K2022 Medicare payment: $7,644 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $34,692 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $234,187 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
20226379$7,644
20231332,220$34,692
20242346,830$234,187

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$15K$29K2017 Drug cost: $6,971 (USD; Tot_Drug_Cst)2018 Drug cost: $864 (USD; Tot_Drug_Cst)2019 Drug cost: $3,023 (USD; Tot_Drug_Cst)2020 Drug cost: $823 (USD; Tot_Drug_Cst)2021 Drug cost: $1,945 (USD; Tot_Drug_Cst)2022 Drug cost: $9,405 (USD; Tot_Drug_Cst)2023 Drug cost: $29,235 (USD; Tot_Drug_Cst)2024 Drug cost: $22,592 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
20173070$6,971
20185673$864
201982146$3,023
20204266$823
202163104$1,945
202289146$9,405
2023103239$29,235
2024150505$22,592

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
G6015Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session33118$251
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more6767$98
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more73110$87
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more3545$64
81001Manual urinalysis test with examination using microscope, automated5668$3

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
MyrbetriqMirabegron15548$8,185
CabergolineCabergoline281,433$5,126
Testosterone CypionateTestosterone Cypionate211,154$1,726
TestosteroneTestosterone22720$1,625
Tamsulosin HclTamsulosin Hcl1658,962$1,553

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.45$1,749COLOPLAST CORP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Wade Willis Muncey, M.D.?

Tedicare shows public-source Medicare data for Wade Willis Muncey, M.D. (NPI 1619408838), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Wade Willis Muncey, M.D. have ACO affiliation data?

Wade Willis Muncey, M.D. is shown with ACO affiliation data for Trinity Health Integrated Care (MSSP, ACO ID A3454).

What billing organization is linked to Wade Willis Muncey, M.D.?

Wade Willis Muncey, M.D. is linked to IDAHO UROLOGIC INSTITUTE PA (billing NPI 1689620692) in the available physician profile data.

Does Wade Willis Muncey, M.D. have Open Payments data?

Wade Willis Muncey, M.D. has 45 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.